Real-world data on denosumab and bisphosphonate use in patients with Solid tumours and Bone metastases in Germany.

Trial Profile

Real-world data on denosumab and bisphosphonate use in patients with Solid tumours and Bone metastases in Germany.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Oct 2017

At a glance

  • Drugs Denosumab (Primary) ; Ibandronic acid; Pamidronic acid; Zoledronic acid
  • Indications Bone metastases; Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Oct 2017 New trial record
    • 12 Oct 2017 Results presented at the 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top